Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Azurity Pharmaceuticals, Inc.

NDC labeler codes: 24338, 52652, 60631

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

49Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
October 23, 2025NDA220256 Clonidine
JAVADIN
Azurity
October 16, 2025NDA219868 Ferumoxytol
FERABRIGHT
Azurity
June 16, 2025NDA219847 Lisdexamfetamine dimesylate
ARYNTA
Azurity
June 5, 2025NDA218395 Meloxicam
XIFYRM
Azurity
June 5, 2025NDA219423 Telmisartan, amlodipine and indapamide
WIDAPLIK
Azurity
January 16, 2025NDA219122 Sitagliptin
BRYNOVIN
Azurity
November 7, 2024NDA219293 Nilotinib
DANZITEN
Azurity
May 1, 2024NDA216482 Mycophenolate mofetil
MYHIBBIN
Azurity
December 7, 2022NDA212209 Bendamustine hydrochloride
VIVIMUSTA
Azurity
July 15, 2022NDA214273 Zonisamide
ZONISADE
Azurity
June 2, 2022NDA216318 Testosterone cypionate
AZMIRO
Azurity
February 4, 2022NDA215602 Baclofen
FLEQSUVY
Azurity
November 5, 2021NDA214679 Topiramate
EPRONTIA
Azurity
November 10, 2020NDA213135 Sodium sulfate, magnesium sulfate, and potassium chloride
SUTAB
Azurity
July 8, 2019NDA211340 Amlodipine (amlodipine benzoate)
KATERZIA
Azurity
April 25, 2017NDA208400 Methotrexate
XATMEP
Azurity
September 20, 2016NDA208686 Enalapril maleate
EPANED
Azurity
July 29, 2016NDA208401 Lisinopril
QBRELIS
Azurity
October 22, 2014NDA205108 Sotalol hydrochloride
SOTYLIZE
Azurity
May 10, 2013NDA203340 Nimodipine
NYMALIZE
Azurity
August 9, 2012ANDA200166 Amphetamine
EVEKEO
Azurity
October 25, 2011ANDA090533 Dextroamphetamine
DEXTROAMPHETAMINE SULFATE
Azurity
February 25, 2011NDA200796 Azilsartan kamedoxomil
EDARBI
Azurity
August 5, 2010NDA022372 Sodium sulfate, potassium sulfate, magnesium sulfate
SUPREP BOWEL PREP KIT
Azurity
June 23, 2005NDA020727 Hydralazine hydrochloride and isosorbide dinitrate
BIDIL
Azurity
Show the other 3 applications

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2023

  1. December 8, 2023 · Class III · Terminated · D-0213-2024 · Topiramate

    Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.

    Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →